Alkalinized lidocaine
PreclinicalSmall molecule
Alkalinized lidocaine is one of 3 small molecule programs targeting Local Anesthetic. It is currently in Preclinical.
2
Indications
6
Total Trials
1
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
7 competitors in Local Anesthetic
#DrugCompanyPhaseTrials
1Glucophage
EMD SeronoApproved
Alkalinized lidocaine
MMassachusetts General Hospital
Preclinical
Phenol
NNorthwestern University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Lidocaine2 trials
Remifentanil1 trial
Efficacy of Alkalinized Lidocaine Compared to Remifentanil on the Incidence of Coughing During Emergence of Anesthesia
Completed·—·N/A·NCT01451840·85 enrolled
Local Anesthetic1 trial
Post Operative Sore Throat1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Alkalinized lidocaine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- MMassachusetts General Hospital